EconPapers: How common is long COVID? Why studies give different answers EconPapers
Economics at your fingertips EconPapers Home About EconPapers Working Papers Journal …

More than 4 years into the global COVID-19 pandemic, widespread infection with severe
acute respiratory syndrome coronavirus 2 (SARSCoV-2) has left millions of people around …

More than three years after SARS-CoV-2 began its global spread, an estimated 65 million or
more people1 are living with the effects of long COVID—and scientists are still struggling to …

Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called 'long
COVID', are rising but little is known about prevalence, risk factors or whether it is possible to …

When the coronavirus pandemic began in early 2020, the SARS-CoV-2 virus was a strange
and terrifying adversary that plunged the world into chaos. More than three years later, the …

Long-COVID treatments: why the world is still waiting IDEAS home Advanced search Economic
literature: papers, articles, software, chapters, books. Authors Institutions Rankings Help/FAQ …

A key unsolved question in the current coronavirus disease 2019 (COVID-19) pandemic is
the duration of acquired immunity. Insights from infections with the four seasonal human …

Long COVID is an often debilitating illness that occurs in at least 10% of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. More than 200 symptoms …

The risk of COVID-19 has been largely communicated only in terms of deaths and hospital
capacity, with recovery and survival conflated with each other. Around one in three people …

The value of large-scale, real-world data—from electronic health records (EHRs), for
example—has been used to establish vaccine efficacy, to elucidate the genetic etiologies of …